Try our beta test site
158 studies found for:    Open Studies | "Blood Platelet Disorders"
Show Display Options
Rank Status Study
21 Recruiting Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia
Conditions: Thrombocytopenia;   Primary Thrombocytopenia,Unspecified;   Thrombocytopenia Chemotherapy Induced
Intervention: Biological: Transfusion of Pooled Platelets Cryopreserved In DMSO
22 Recruiting A Rollover Study to Provide Continued Treatment With Eltrombopag
Condition: Thrombocytopaenia
Intervention: Drug: ELT
23 Recruiting Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.
Condition: Thrombocytopenia
Intervention: Drug: Eltrombopag
24 Recruiting A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
Conditions: Alloimmune Thrombocytopenia;   Fetal Alloimmune Thrombocytopenia
Intervention: Drug: IVIG (Intravenous Immunoglobulin)
25 Not yet recruiting Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
Condition: Neonatal Alloimmune Thrombocytopenia
Intervention: Procedure: Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion
26 Recruiting Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates
Condition: Neonatal Thrombocytopenia
Intervention:
27 Recruiting A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: AMG531
28 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platelet count);   Drug: avatrombopag (higher baseline platelet count);   Drug: placebo (higher baseline platelet count)
29 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platelet count);   Drug: avatrombopag (higher baseline platelet count);   Drug: placebo (higher baseline platelet count)
30 Not yet recruiting Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing
Condition: Cytopenia
Intervention: Procedure: Bone Marrow Aspirate
31 Recruiting Molecular Biology of Polycythemia and Thrombocytosis
Conditions: Polycythemia;   Thrombocytosis
Intervention:
32 Recruiting Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants
Conditions: Thrombotic Microangiopathy;   Disorder Related to Bone Marrow Transplantation
Intervention: Drug: eculizumab
33 Not yet recruiting Screening of TMA Patients für ADAMTS13 Activity (Adamscreen)
Condition: Thrombotic Microangiopathies
Intervention: Biological: Technozyme
34 Available OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy
Condition: Thrombotic Microangiopathy
Intervention: Biological: OMS721
35 Recruiting Observational Trial of a Therapeutic Platelet Transfusion Regimen
Conditions: Acute Myeloid Leukemia;   Thrombocytopenia
Intervention:
36 Recruiting Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
Conditions: Antineoplastic Adverse Reaction;   Thrombocytopenia;   Acute Myelocytic Leukemia
Intervention: Drug: rhTPO
37 Recruiting Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies
Condition: Thrombotic Microangiopathies
Intervention: Biological: OMS721
38 Not yet recruiting PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
Conditions: Chronic Phase Myelofibrosis;   Primary Myelofibrosis;   Post-essential Thrombocythemia Myelofibrosis;   Polycythemia Vera
Intervention: Drug: Pembrolizumab
39 Not yet recruiting Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms
Conditions: Polycythemia Vera;   Essential Thrombocythemia
Intervention: Biological: RNA sample of total leukocytes before start of treatment
40 Recruiting Familial Myeloproliferative Disorders
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Idiopathic Myelofibrosis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.